Replication Stress (RS) is a type of DNA damage generated at the replication fork, characterized by singlestranded DNA (ssDNA) accumulation, and which can be caused by a variety of factors. Previous studies have reported elevated RS levels in aged cells. In addition, mouse models with a deficient RS response show accelerated aging. However, the relevance of endogenous or physiological RS, compared to other sources of genomic instability, for the normal onset of aging is unknown. We have performed long term survival studies of transgenic mice with extra copies of the Chk1 and/or Rrm2 genes, which we previously showed extend the lifespan of a progeroid ATR-hypomorphic model suffering from high levels of RS. In contrast to their effect in the context of progeria, the lifespan of Chk1, Rrm2 and Chk1/Rrm2 transgenic mice was similar to WT littermates in physiological settings. Most mice studied died due to tumors -mainly lymphomas-irrespective of their genetic background. Interestingly, a slightly higher percentage of transgenic mice developed tumors compared to WT mice. Our results indicate that supraphysiological protection from RS does not extend lifespan, indicating that RS may not be a relevant source of genomic instability on the onset of "normal" aging. instability over time can cause cellular senescence and apoptosis in the case of aging, in other cases it can lead to uncontrolled cellular proliferation, and is therefore associated with an increased cancer risk [3, 4] .
Introduction
For decades, researchers have investigated the process of aging: a decline in health over time, which is generally considered to be due to an accumulation of cellular damage [1, 2] . This cellular damage has different causes, but genomic instability is considered one of the main factors that contribute to cellular aging [3] . Genetic damage such as point mutations, chromosomal rearrangements, aneuploidy and copy number variations accumulate during life and are caused by endogenous and exogenous sources, including UV radiation, ionizing radiation and reactive oxygen species (ROS) [3, 4] . While the accumulation of genomic to that of human patients, which is further aggravated in combination with several cancer-driving mutations such as the Myc oncogene or the absence of the tumor suppressor p53 [12, 23] . ATR-Seckel mice show high levels of RS during embryonic development, accelerated aging in adult life and early lethality [12] . Interestingly, mice harbouring extra alleles of CHK1 (Chk1 Tg ) or of the ribonucleotide reductase (RNR) regulatory subunit RRM2 (Rrm2 Tg ), which is a limiting factor for dNTP production, improved the lifespan and alleviated the progeroid phenotype of ATR mutant mice [24, 25] . These Chk1 and Rrm2 transgenic mice carry bacterial artificial chromosome (BAC) alleles of the respective genes, including exons and intron, under their own endogenous promoters. This strategy provides supraphysiological levels of these factors while preventing overexpression in tissues where these genes are normally not expressed, and was proven successful with the Trp53 BAC-transgenic mouse model [26] . Collectivelly, these studies suggested that RS might have important implications in mammalian aging. However, the effect of Chk1 and Rrm2 expression levels on normal aging, in mice with physiological levels of ATR, remains to be elucidated.
In the current study, we investigated the effect of supraphysiological levels of CHK1 and RRM2, which confer extra protection against RS, on normal aging. We utilized cohorts of WT, Chk1 Tg , Rrm2 Tg and Chk1 Tg ;Rrm2 Tg mice to asses tumor-free survival of these mice. We found no differences in survival between the genotypes and all mice exhibited similar signs of aging, although there was a slightly higher tumor incidence in the transgenic mice compared to WT mice. In the light of these data, we propose that endogenous RS is not a major source of DNA damage contributing to normal aging.
Results

Generation of mice with supraphysiological levels of CHK1 and RRM2
In order to investigate the effect of RS on lifespan, we used the Chk1 Tg and Rrm2 Tg mouse models previously generated in our laboratory [24, 25] . Chk1 Tg and Rrm2 Tg mice were crossed in order to obtain Chk1 Tg , Rrm2 Tg and Chk1 Tg ;Rrm2 Tg mice. Transgenic mice were not phenotypically distinguishable from WT littermates and were born in accordance with Mendelian ratios (Chi-square p-value = 0.243) ( Table 1 ). 
MEFs with increased levels of RRM2 and CHK1 are protected against RS
To confirm that supraphysiological levels of CHK1 and RRM2 could protect cells against RS, we generated mouse embryonic fibroblasts (MEFs) from crosses between Chk1 Tg and Rrm2 Tg mice. Chk1 Tg and Rrm2 Tg MEFs have been previously described to be resistant to RS induced by the ribonucleotide reductase inhibitor hydroxyurea (HU) [24, 25] . Genomic PCR genotyping confirmed the four different MEF genotypes:
WT, Chk1 Tg , Rrm2 Tg and Chk1 Tg ;Rrm2 Tg (Fig. 1a ). In addition, increased protein levels of RRM2 and CHK1 in MEFs carrying the Rrm2 or Chk1 transgene were confirmed by Western blotting (Fig. 1b ).
We then assessed whether elevated levels of CHK1 and RRM2 would influence cell proliferation, and found that Chk1 Tg and Chk1 Tg ;Rrm2 Tg MEFs proliferated similarly to WT MEFs ( Fig. 1c ). Rrm2 Tg MEFs showed a mild increased proliferation compared to the other MEFs, which was consistent with an EdU staining revealing more S phase cells in the Rrm2 Tg population compared to WT, Chk1 Tg and Chk1 Tg ;Rrm2 Tg cells ( Fig. 1d ).
Next, we assessed whether MEFs carrying extra copies of Rrm2 and Chk1 were protected against RS by assessing γH2AX levels in these cells. Using high-content microscopy, we found that Chk1 Tg , Rrm2 Tg and Chk1 Tg ;Rrm2 Tg MEFs have lower basal levels of γH2AX compared to WT MEFs (Fig. 1e,f ). In addition to assessing γH2AX levels in unstressed conditions, we induced RS by treating the cells with CHK1-inhibitor UCN-01 at different doses and found that the cells with higher CHK1 and/or RRM2 levels showed a decrease in γH2AX intensity compared to WT MEFs (Fig. 1e ). In addition, the MEFs were treated with HU ( Fig. 1f ). In accordance with previously published data on Chk1 and Rrm2 transgenic MEFs, we observed lower γH2AX intensity in these MEFs compared to WT. More importantly, the lowest levels of γH2AX intensity were observed in Chk1 Tg ;Rrm2 Tg MEFs. These data confirm that cells from mice carrying extra copies of the Rrm2 or Chk1 genes are protected from RS.
Supraphysiological levels of CHK1 and RRM2 do not influence lifespan in mice
Next, we aimed to investigate whether the protection against RS conferred by extra copies of Chk1 and
Rrm2 would be reflected in the survival of mice, as they did in the context of reduced levels of ATR [24, 25] .
To this end, we used mice containing the Chk1 and/or Rrm2 transgenes, and assessed tumor-free survival of these mice. Mice were euthanized when they had noticeable tumors or were visibly ill, as observed by rapid weight loss, hunched posture, rough hair coat, labored breathing, lethargy, impaired mobility or abdominal swelling. Only female mice were included in the cohorts, since they could be group-housed more easily than males.
Our results show that survival was not increased due to CHK1 or RRM2 levels: the survival of WT, Chk1 Tg , Rrm2 Tg and Chk1 Tg ;Rrm2 Tg was not significantly different (log-rank p=0.3944) ( Fig. 2a ). We collected tissues of two year-old mice (not included in survival curve). H&E staining of spleens, livers and kidneys of mice did not show obvious differences between the genotypes (Fig. 2b) . Furthermore, we observed no noticeable differences in appearance among the mice with different genotypes, as reflected by their weight at 1 year of age ( Fig. 2c ). In addition, all mice displayed comparable signs of aging such as weight loss, grey hair and baldness (data not shown). In summary, unlike in an ATR-deficient background, extra copies of Chk1 and
Rrm2 did not increase the overall survival of mice.
Extra copies of Chk1 and Rrm2 mildly increase the prevalence of spontaneous tumors
While none of the genetic combinations used in this study was able to extend mouse lifespan, the median survival of Chk1 Tg ;Rrm2 Tg mice was the lowest with 100 weeks compared to 123 weeks for WT mice (not statistically significant). In addition, and despite no significant differences on overall survival, the percentage of mice that developed tumors was higher for the mice containing extra copies of Chk1, Rrm2
or both transgenes (74%, 70% and 71%, respectively) compared to the percentage of WT mice with tumor (64%), which could be in line with previous reports indicating that overexpression of CHK1 or RRM2 favors tumorigenesis ( Fig. 3a ) [27, 28] . The majority of the observed tumors were lymphomas, which was confirmed by an enlarged spleen or lymph nodes containing CD3e positive cells (Fig. 3b ). This is in agreement with our previous reports showing that increased CHK1 or RRM2 levels can reduce the DNA damage induced by oncogenes thereby facilitating oncogenic transformation or cell reprogramming [25, 29, 30] .
Discussion
In the presented study, we aimed to determine whether protection against RS could extend mammalian lifespan by utilizing mouse models with supraphysiological levels of CHK1 and RRM2. These BAC-transgenic mouse models contain extra copies of the genes of interest, which keep the expression of the genes in a physiological range and maintain their endogenous regulation and has been a successful strategy in the past [15, 26] . Previous studies have shown that defects in RS-related proteins lead to increased RS levels and accelerated aging [12, 31, 32] . Lopez-Otin and colleagues described in 2013 the hallmarks of aging [3] , one of them being DNA damage. However, a hallmark of aging should not only cause accelerated aging when aggravated, but also increase lifespan when attenuated [3] .
We showed that CHK1-and RRM2-overexpressing MEFs have lower levels of DNA damage in basal conditions and have greater protection against HU-and UCN-01-induced RS, and we hypothesized that this protection against RS could lead to an increase in lifespan in vivo. However, we did not observe a difference in lifespan between Chk1 Tg , Rrm2 Tg and Chk1 Tg ;Rrm2 Tg and WT mice, and all mice developed similar agerelated symptoms. Based on these results we conclude that supraphysiological levels of CHK1 and RRM2 do not influence normal aging, and more generally, we propose that physiological RS might not be an important driver of aging. Although Chk1 Tg and Rrm2 Tg mice were previously shown to extend the lifespan and alleviate the progeroid symptoms of ATR-deficient mice [24, 27] , this is not a direct indication that CHK1 and RRM2 levels influence normal aging. CHK1 overexpression could compensate for ATR deficiency, as CHK1 is a downstream target of ATR. For RRM2 this connection to the ATR pathway is not as direct, although studies in yeast have shown that ATR ortholog Mec1 can activate the ribonucleotide reductase (RNR) complex [33, 34] . Therefore, extra levels of RRM2 could also partially compensate for ATR deficiency.
Interestingly, a slightly higher fraction of the Chk1 and Rrm2 transgenic mice developed tumors, primarily lymphomas, compared to WT mice. The exact role of the RS response in regard to tumorigenesis is complex [35, 36] . On the one hand, CHK1 is known as a tumor suppressor, and its expression can induce senescence and apoptosis, thereby limiting tumorigenesis [37, 38] . On the other hand, experiments with Chk1 Tg MEFs have shown that overexpression of CHK1 can promote oncogenic transformation, and elevated CHK1 levels are present in lymphomas, suggesting that CHK1 could also have a role in promoting tumorigenesis [27, 39] .
In relation to RRM2, nucleoside supplementation has been shown to both limit and promote transformation [40, 41] . In addition, increased nucleotide levels can lead to errors during DNA replication and tumorigenesis [28, 42] . Our findings favor the concept that RS is not a requirement for transformation, but also that protection against RS does not prevent tumorigenesis.
Furthermore, the increased tumor incidence in Chk1 and Rrm2 transgenic mice could affect their survival, as is the case for TERT-overexpressing mice. Several Tert trangenic mouse models have an increased incidence of spontaneous tumors [43] [44] [45] [46] . Thus, extension of lifespan by TERT-overexpression is only possible in the context of a cancer-resistant background [16] . Since we observed a slightly higher tumor incidence in Chk1 and Rrm2 transgenic mice, these mice could possibly survive longer in a cancer-resistant background. Also, the process of aging is complex and influenced by different factors. Conversely, overexpression of DNA damage proteins may improve several aspects of aging, but not the aging process as a whole, and therefore we cannot rule out the involvement of RS on aging. Nevertheless, our data indicate that RS might not be a relevant contributing factor to normal aging in mice.
Methods
Mouse husbandry
Chk1 Tg and Rrm2 Tg mouse models have been described previously [24, 25] . Both strains have a mixed 
Primers for PCR Genotyping
Mice were genotyped using the following primers: gRrm2_Fw (TGTCCTGGAGAGCCAGTCTT), gRrm2_Rev
(AAGGAGGGAGGGAGGCTATT) and gRrm2_Transgen (ACTGGCCGTCGTTTTACAAC) for the Rrm2 locus and gChk1_Fw (TGTCTTCCCTTCCCTGCTTA), gChk1_Rev (TCCCAAGGGTCAGAGATCAT) and gChk1_Transgen (GTAAGCCAGTATACACTCCGCTA) for the Chk1 locus. Expected band sizes are 265 bp for the Rrm2 + , 380 bp for the Rrm2 Tg , 400 bp for the Chk1 + and 270 bp for the Chk1 Tg allele.
Cell culture
Mouse embryonic fibroblasts (MEFs) were generated from 13.5 dpc mouse embryos according to standard procedures. MEFs were cultured in Dulbecco's Modified Eagle Medium (DMEM; Gibco) supplemented with 15% heat-inactivated fetal bovine serum (FBS; ThermoFisher Scientific) and 1% penicillin-streptomycin (ThermoFisher Scientific).
Proliferation assay
Early-passage MEFs were plated at a density of 100.000 cells per well of a 6-well plate. Every three to four days, cells were counted and re-seeded at a density of 100.000 wells per well. 
Western blotting
Cells were lysed in RIPA buffer (Sigma-Aldrich R0278) supplemented with protease (Roche 4693132001) and phosphatase inhibitors (Sigmal-Aldrich P0044). Western blot analysis was performed according to standard procedures. Primary antibodies used were anti-CHK1 (Novocastra), anti-RRM2 (Santa Cruz Biotechnology, SC-10844) and anti-β-actin (Sigma-Aldrich, A5441).
Histopathology
Mouse tissues were fixed in formalin and processed for immunohistochemistry (IHC) by HistoWiz Inc.
(histowiz.com) or the Histopathology unit at the Spanish National Cancer Research Center (CNIO). 
Figure legends
